EUSA Pharma Competitors and Similar CompaniesClear all

EUSA Pharma's competitors and similar companies include Exscientia, Immunomedics and BioLineRx.

	EUSA Pharma EUSA Pharma is a biopharmaceutical company focused on oncology and rare diseases.	Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.	Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.	BioLineRx BioLineRx is a biopharmaceutical company focused on oncology.
Founding Date	Founding Date 2015	Founding Date 2012	Founding Date 1982	Founding Date 2003
Type	Type Private	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech oncology pharma	Tags Technology artificial intelligence drug development oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Hemel Hempstead, GB HQ	Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US	Locations Morris Plains, US HQ	Locations Modi'in-Maccabim-Re'ut, IL HQ
Employees	Employees 965% decrease	Employees 88	Employees 8914% decrease	Employees 2414% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) £20.1m (FY, 2023)	Revenue (est.) $295k (FY, 2019)	Revenue (est.) $1.2m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods £10.5m (FY, 2023)	Cost of goods N/A	Cost of goods $230k (FY, 2025)
Gross profit	Gross profit N/A	Gross profit £10.8m (FY, 2023)	Gross profit $295k (FY, 2019)	Gross profit $950k (FY, 2025)
Net income	Net income N/A	Net income (£146m) (FY, 2023)	Net income ($357.3m) (FY, 2019)	Net income ($2m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 54.2m	Total funding raised $ 430.2m	Total funding raised $ 30m	Total funding raised $ 100.9m